Literature DB >> 35639134

Excess costs of mental disorders by level of severity.

Hannah König1, Hans-Helmut König2, Jürgen Gallinat3, Martin Lambert3, Anne Karow3, Judith Peth4, Holger Schulz4, Alexander Konnopka2.   

Abstract

INTRODUCTION: Mental disorders are highly prevalent in Germany, and associated with decreased quality of life for those affected as well as high economic burden for the society. The purpose of this study was to determine the excess costs of mental disorders and to examine how these differ with respect to disease severity.
METHODS: We analyzed mean 6-month costs using the baseline data from the RECOVER trial in Hamburg, Germany, which evaluates an innovative stepped-care model for mental disorders. Four severity levels were classified based on the current level of mental illness, loss of functioning, and psychiatric diagnosis. In this work, direct costs (outpatient, inpatient, and social/informal care) and indirect costs (sick leave, unemployment, and early retirement) were estimated using interview-based data on health care utilization and productivity losses. Excess costs were determined by matching a comparison group of the German general population without mental disorders. Group differences in sociodemographic covariates and somatic comorbidities were balanced using entropy balancing. Excess costs by severity levels were estimated using generalized linear models (GLM) with gamma distribution and log-link function.
RESULTS: Overall, the RECOVER group included n = 816 and the comparison group included n = 3226 individuals. Mean total 6-month excess costs amounted to 19,075€, with higher indirect excess costs (13,331€) than direct excess costs (5744€) in total excess costs. The excess costs increased with increasing disease severity, ranging from 6,123€ with mild disease severity (level 1) to 31,883€ with severe mental illness (level 4). Indirect excess costs ranged from 5612€ in level 1 to 21,399€ in level 4, and were statistically significant for all disease severity levels. In contrast, direct excess costs were only statistically significant for the levels 2 to 4, and ranged from 511€ in level 1 to 10,485€ in level 4. The main cost drivers were hospital stays (level 2-4), sick leave and unemployment (all levels), and early retirement (level 3-4). DISCUSSION: Mental disorders are associated with high costs that increase with the level of disease severity, which was also shown for individual ICD-10 diagnosis groups. Due to their influence on costs, indirect costs and disease severity levels should be considered in future cost-of-illness studies of mental disorders. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov, trial registration number NCT03459664.
© 2022. The Author(s).

Entities:  

Keywords:  Cost of Illness; Disease severity; Health Services Research; Mental disorders

Year:  2022        PMID: 35639134     DOI: 10.1007/s00127-022-02298-8

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  42 in total

1.  Self-reported utilization of mental health services in the adult German population--evidence for unmet needs? Results of the DEGS1-Mental Health Module (DEGS1-MH).

Authors:  Simon Mack; Frank Jacobi; Anja Gerschler; Jens Strehle; Michael Höfler; Markus A Busch; Ulrike E Maske; Ulfert Hapke; Ingeburg Seiffert; Wolfgang Gaebel; Jürgen Zielasek; Wolfgang Maier; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2014-03-31       Impact factor: 4.035

Review 2.  Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review.

Authors:  Peter Bower; Simon Gilbody
Journal:  Br J Psychiatry       Date:  2005-01       Impact factor: 9.319

Review 3.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

Review 5.  [The German community mental health system-a review].

Authors:  Peter Brieger
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-02       Impact factor: 1.513

6.  Cost of disorders of the brain in Europe 2010.

Authors:  Anders Gustavsson; Mikael Svensson; Frank Jacobi; Christer Allgulander; Jordi Alonso; Ettore Beghi; Richard Dodel; Mattias Ekman; Carlo Faravelli; Laura Fratiglioni; Brenda Gannon; David Hilton Jones; Poul Jennum; Albena Jordanova; Linus Jönsson; Korinna Karampampa; Martin Knapp; Gisela Kobelt; Tobias Kurth; Roselind Lieb; Mattias Linde; Christina Ljungcrantz; Andreas Maercker; Beatrice Melin; Massimo Moscarelli; Amir Musayev; Fiona Norwood; Martin Preisig; Maura Pugliatti; Juergen Rehm; Luis Salvador-Carulla; Brigitte Schlehofer; Roland Simon; Hans-Christoph Steinhausen; Lars Jacob Stovner; Jean-Michel Vallat; Peter Van den Bergh; Peter Van den Bergh; Jim van Os; Pieter Vos; Weili Xu; Hans-Ulrich Wittchen; Bengt Jönsson; Jes Olesen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09-15       Impact factor: 4.600

7.  Functional disability and quality of life decrements in mental disorders: Results from the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH).

Authors:  Simon Mack; Frank Jacobi; Katja Beesdo-Baum; Anja Gerschler; Jens Strehle; Michael Höfler; Markus A Busch; Ulrike Maske; Ulfert Hapke; Wolfgang Gaebel; Jürgen Zielasek; Wolfgang Maier; Hans-Ulrich Wittchen
Journal:  Eur Psychiatry       Date:  2015-07-10       Impact factor: 5.361

8.  Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH).

Authors:  Frank Jacobi; Michael Höfler; Jens Siegert; Simon Mack; Anja Gerschler; Lucie Scholl; Markus A Busch; Ulfert Hapke; Ulrike Maske; Ingeburg Seiffert; Wolfgang Gaebel; Wolfgang Maier; Michael Wagner; Jürgen Zielasek; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2014-04-11       Impact factor: 4.035

9.  The excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria.

Authors:  Agata Łaszewska; Johannes Wancata; Rebecca Jahn; Judit Simon
Journal:  Eur J Health Econ       Date:  2020-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.